Diets rich in certain plant-based foods are linked with the presence of gut microbes that are associated with a lower risk of developing conditions such as obesity, type 2 diabetes and cardiovascular disease, according to […]
Eligo Bioscience SA (Eligo) today announced that it has entered into a research and option agreement with GlaxoSmithKline (NYSE: GSK) aimed at advancing Eligobiotics® for the treatment or prevention of acne vulgaris with a pioneering […]
Bacteria often show very strong biogeography – some bacteria are abundant in specific locations while absent from others – leading to major questions when applying microbiology to therapeutics or probiotics: how did the bacteria get […]
We live in a world invaded by plastic. Its role as a chemically stable, versatile and multi-purpose fostered its massive use, which has finally translated into our current situation of planetary pollution. Moreover, when plastic […]
The regulatory environment for live biotherapeutic products is still uncertain globally, of course, but one booming area is the manufacturing of these products as they move through their clinical development process. Adrien Nivoliez, CEO of Biose Industrie reflects on […]
It’s not stress that kills us; it is our reaction to it” are the famous words of the Hungarian physiologist Hans Selye. Indeed understanding how stress affects the body is an important endeavour in understanding […]
From the perspective of A. Murat Eren, PhD, the mouth is the perfect place to study microbial communities. “Not only is it the beginning of the GI tract, but it’s also a very special and […]
The balance of microbiota in the gut has a significant effect on general wellbeing, as well as clear associations with many diseases and a patient’s response to certain treatments. The role of the microbiota in […]
In recent years, the microbiota — the community of bacteria and other microorganisms that live on and in the human body — has captured the attention of scientists and the public, in part because it’s […]
The Regents of the University of California and Evolve BioSystems are pleased to announce that an Illinois federal judge has recently denied a motion by Abbott Laboratories to dismiss a patent infringement suit jointly filed […]
Every microbiome-focused company has its own approach for discovering drug candidates—but rarely is the mechanism of action for a live biotherapeutic product (LBP) known from the outset. Microbiome pharma company ImmunoBiome, however, uses a unique […]